Smokescreen Studies

The following studies use the Smokescreen chip.

Study 31 – Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT); CTN-0051

Ancillary Study: Contribution of Specified Opioid Receptor Gene Variants to Outcome of Extended Release Naltrexone vs. Buprenorphine/Naloxone Treatment for Opioid Dependence Investigators:  John Rotrosen, M.D. (NYU Langone Medical Center); Ancillary Study: Mary Jeanne Kreek, M.D. (Rockefeller University) Status:  Available at dbGaP dbGaP Accession ID:  phs002876.v1.p1 dbGaP Release Date: 05/25/2022 View Study in Clinical Trials Network Site Abstract:  For opioid-dependent patients...

Read more ...

Study 42 – Genetics Analysis of Substance Use Disorder Using the Indiana Biobank Data

Investigators:  Dongbing Lai, Ph.D., Tae-Hwi Linus Schwantes-An, Ph.D., & Howard J. Edenberg, Ph.D. Status: Available at dbGaP dbGaP Accession ID: phs003025.v1.p1 dbGaP Release Date: 04/07/2023 Objective: The goal of this study is to identify genes related to substance use disorders, both individually (e.g. opioid, cannabis, cocaine, etc.) as well as those related to substance use disorders in general. The study...

Read more ...

Study 46 – Advancing Genomics Research of Substance Use Disorders in Latin American Populations

Principal Investigators: Janitza Montalvo-Ortiz, Ph.D., Humberto Nicolini, Ph.D dbGaP Accession ID:  phs003558.v1.p1 dbGaP Release Date: 05/01/2025 Objective: Latin American populations are widely underrepresented in genomic studies of substance use disorders. This project aims to analyze the genetics of substance use disorders in Latin American populations, thus increasing the representation of this population in such studies, particularly from Mexico, Chile, and...

Read more ...

Study 51 – Genotyping on Smokescreen Microarray Chip

Investigators:  Jasmin Vassileva and Alexandre Todorov Status: Available at dbGaP dbGaP Accession IDs: PI: Vassileva; Sites 500 & 518; phs001647.v1.p1 PI: Todorov; Site 501; phs001804.v1.p1 Release Dates:  Sites 500 & 518: 12/16/2021 Site 501: 06/28/2019 Files Instrument References

Read more ...

Study 52 – Genetic Contribution to the Abuse Liability of Oxycodone

Investigator:  Jermaine Jones Status: Available at dbGaP dbGaP Accession ID:  phs001559.v1.p1 dbGaP Release Date:  08/23/2018 Files Instrument References

Read more ...

Study 53 – The Women’s Interagency HIV Study (WIHS)

Investigator:  Brad Aouizerat Status: Available at dbGaP dbGaP Accession ID:  phs001503.v1.p1 dbGaP Release Date:  05/14/2018 Files Instrument References

Read more ...

Study 54 – Genotyping on Smokescreen Microarray Chip

Investigator:  Deborah Mash Status: Available at dbGaP dbGaP Accession ID:  phs001377.v1.p1 dbGaP Release Date:  10/02/2017 Files Instrument References

Read more ...

Study 55 – ALIVE Cohort Smokescreen GWAS

Investigator:  Brion Maher Status: Available at dbGaP dbGaP Accession ID:  phs001494.v1.p1 dbGaP Release Date:  03/14/2018 Files Instrument References

Read more ...

Study 56 – Assess the Cardiovascular, Cognitive, and Subjective Effects of Atomoxetine in Combination with IV Methamphetamine

Investigator:  Edythe D. London Status: Available at dbGaP dbGaP Accession ID:  phs001195.v1.p1 dbGaP Release Date:  03/29/2018 Files Instrument References

Read more ...

Study 57 – Neural Systems, Inhibitory Control, and Methamphetamine Dependence

Investigator:  Edythe D. London Status: Available at dbGaP dbGaP Accession ID:  phs001197.v1.p1 dbGaP Release Date:  05/01/2018 Files Instrument References

Read more ...

Study 58 – Early Methamphetamine Abstinence fMRI and Brain Function

Investigator:  Edythe D. London Status: Available at dbGaP dbGaP Accession ID:  phs001198.v1.p1 dbGaP Release Date:  06/01/2018 Files Instrument References

Read more ...

Study 59 – Smokescreen; Opioid/Cocaine Use; Antisocial Drug Dependence

Investigator:  Robin Corley Status: Available at dbGaP dbGaP Accession ID:  phs001841.v1.p1 dbGaP Release Date:  06/03/2021 Files Instrument References

Read more ...

Study 60 – Gene-Environment Interactions in COCCaINE Use Disorder: Collaborative Case-Control Initiative in Cocaine Addiction

Investigator:  Rodrigo Grassi-Oliveira Status: Available at dbGaP dbGaP Accession ID:  phs001810.v2.p2 dbGaP Release Date:  09/27/2022 Files Instrument References

Read more ...

Study 61 – Smokescreen; NJD/NID cohort

Investigator:  Stanley Weiss Status: Available at dbGaP dbGaP Accession ID:  phs002140.v1.p1 dbGaP Release Date:  10/16/2023 Files Instrument References

Read more ...

Study 62 – Prevention of Viral Hepatitis and HIV in Drug Users – A Hepatitis B Model for HIV and an HB Vaccine Model (DASH)

Investigator:  Lu-Yu Hwang Status: Available at dbGaP dbGaP Accession ID:  phs002331.v1.p1 dbGaP Release Date:  06/03/2021 Files Instrument References Contributing PIs:  Lu-Yu Hwang dbGaP Accession:  phs002331 Study Alias:  Smokescreen; DASH

Read more ...

Study 63 – Smokescreen; InC3 cohort substance abusers

Investigator:  Kimberly Page Status: Available at dbGaP dbGaP Accession ID:  phs002310.v1.p1 dbGaP Release Date:  05/18/2021 Files Instrument References

Read more ...

Study 64 – Smokescreen; Centers for AIDS Research (CFAR) Network of Integrated Clinical Systems (CNICS)

Investigator:  Inga Peter Status: Available at dbGaP dbGaP Accession ID:  phs001788.v1.p1 dbGaP Release Date:  01/21/2020 Files Instrument References

Read more ...

Study 65 – Spit for Science™

Investigator:  Danielle Dick Status: Available at dbGaP dbGaP Accession ID:  phs001754.v1.p1 dbGaP Release Date:  06/06/2019 Overview: Spit for Science™ is a university-wide research opportunity with the scientific goal of understanding how genetic and environmental factors come together to influence substance use and emotional health across the college years and beyond. To address this goal, we have comprehensively and longitudinally studied eligible incoming freshmen (18 years or older) from...

Read more ...